SERVICE OFFERINGS
The Tx Accelerator focuses on early-stage biotherapeutic ventures with the potential for significant market impact. This is a service for equity model with up to $150K provided in integrated services per venture with 5% common equity due only if the company raises more than $3M (at a valuation of at least $4M). Integrated services include:
Tx Accelerator provides office and lab spaces at two adMare locations, Montreal and Vancouver, and in partnership with MaRS in Toronto. Access to basic and specialized equipment is provided at each site.
Under an NDA, selected ventures will undergo a due diligence process prior to finalization, and are expected to grant access to a data room or directly provide:
Interested ventures are invited to submit their full applications by sending the required information and company presentation by March 1st, 2023.
In case you have any questions regarding the application for the National Accelerator Program, please send an email to Senior Director, National Accelerator Program, Milica Vukmirovic, at mvukmirovic@admarebio.com
Stellar academic research is the foundation of all adMare BioInnovations’ drug development and commercialization efforts. We work with academic researchers and Biotech founders across the country to proactively identify and collaborate on innovative science and research.
adMare BioInnovations provides seed capital, scientific guidance, business expertise, state-of-the-art lab space, vivarium and office space infrastructure, access to C-suite executives, investors, and industry partners required to help build Canada’s next-generation biotech companies.
Yes. However, applications must be submitted by March 1st, 2023, to be included in the first cohort of companies. After the first cohort is selected, applications will be considered on a rolling- basis throughout the year, depending on capacity.
Membership in other commercialization programs or accelerators will be considered on a case by case and in the context of the venture’s plans for technology development and commercialization.
The DD process involves the presentation of the venture’s goals and technology development plan to an internal selection committee under confidentiality. Ventures will also be requested to provide access to data, IP, organizational and business-related materials during the DD process. Each venture should anticipate being in active communication with our team over a two-week period for the DD process.
All Canadian-incorporated companies are invited to apply to the Tx Accelerator. However, we only have wet lab and office spaces available in BC, QC, and ON. Please determine which location is best suited for your company.
Upon acceptance to the Tx Accelerator, each company will enter into an agreement outlining the support that will be provided by the program. Acceptance into the accelerator program does not mean that adMare BioInnovations or its regional partners will automatically provide a direct investment (equity) or continuous funding support for your venture. Direct and in-kind support will be provided to each venture depending on the needs determined at intake.
Several webinars and office hours sessions will be held to provide additional information on the Tx Accelerator.
Please refer to the list of scheduled webinars and events below. Registration is required in order to access the webinar and/or attend in person.
For more information on the adMare Tx Accelerator and how to apply, watch our webinar with Milica Vukmirovic, Senior Director, National Accelerator.
Please connect with the Senior Director, National Accelerator Program Dr. Milica Vukmirovic at mvukmirovic@admarebio.com to schedule time for additional consultations.